Literature DB >> 8060154

Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis.

J C Tsai1, K R Feingold, D Crumrine, L C Wood, C Grunfeld, P M Elias.   

Abstract

Previous studies have shown that (1) epidermal TNF alpha mRNA levels are increased following acute disruption of the cutaneous permeability barrier; (2) this increase is maximal at 1 h and decreases to control levels by 8 h; and (3) in essential fatty acid-deficient (EFAD) mice, a chronic model of barrier perturbation, TNF alpha mRNA levels are also elevated several-fold over controls. In the present study we determined, using immunocytochemical procedures, epidermal TNF alpha protein levels following either acute of chronic barrier disruption and the localization of any increase. Frozen, paraffin and Antibed sections of skin were incubated with polyclonal anti-mouse TNF alpha antisera and detection was accomplished by either immunoperoxidase or fluorescence procedures. We found that (1) TNF alpha-immunoreactive protein was present in normal mouse epidermis, and was primarily localized to the upper nucleated layers where it displayed a diffuse cytosolic pattern; (2) acute disruption of the barrier with acetone or tape-stripping resulted in TNF alpha staining that was more intense throughout all of the nucleated epidermal cell layers in comparison with normal epidermis; (3) the increase in TNF alpha staining occurred as early as 2 h after barrier disruption; and (4) increased TNF alpha staining was also observed in the stratum corneum of EFAD mice. These results indicate that epidermal TNF alpha protein levels increase after both acute and chronic barrier disruption, and are consistent with the hypothesis that TNF alpha may signal and/or coordinate portions of the cutaneous response to barrier disruption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060154     DOI: 10.1007/bf00387595

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis.

Authors:  G Kolde; K Schulze-Osthoff; H Meyer; J Knop
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 2.  Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations.

Authors:  T S Kupper
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Production of cytokines by epithelial tissues. A new model for cutaneous inflammation.

Authors:  T S Kupper
Journal:  Am J Dermatopathol       Date:  1989-02       Impact factor: 1.533

4.  Lipid content and lipid type as determinants of the epidermal permeability barrier.

Authors:  G Grubauer; K R Feingold; R M Harris; P M Elias
Journal:  J Lipid Res       Date:  1989-01       Impact factor: 5.922

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

7.  Interleukin-6 and tumour necrosis factor alpha are expressed by keratinocytes but not by Langerhans cells.

Authors:  A Oxholm; M Diamant; P Oxholm; K Bendtzen
Journal:  APMIS       Date:  1991-01       Impact factor: 3.205

Review 8.  Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha).

Authors:  I Kimber; M Cumberbatch
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

9.  Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis.

Authors:  L Didierjean; D Salomon; Y Mérot; G Siegenthaler; A Shaw; J M Dayer; J H Saurat
Journal:  J Invest Dermatol       Date:  1989-06       Impact factor: 8.551

10.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

Authors:  A Köck; T Schwarz; R Kirnbauer; A Urbanski; P Perry; J C Ansel; T A Luger
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Skin innate immune system in psoriasis: friend or foe?

Authors:  B J Nickoloff
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss.

Authors:  M Denda; L C Wood; S Emami; C Calhoun; B E Brown; P M Elias; K R Feingold
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

Review 3.  Current status and future prospects of transdermal drug delivery.

Authors:  R H Guy
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 4.  Laser vaccine adjuvants. History, progress, and potential.

Authors:  Satoshi Kashiwagi; Timothy Brauns; Jeffrey Gelfand; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Sampling of disease biomarkers from skin for theranostic applications.

Authors:  Makoto Ogura; Sumit Paliwal; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

Review 6.  The role of the epidermis and the mechanism of action of occlusive dressings in scarring.

Authors:  Thomas A Mustoe; Anandev Gurjala
Journal:  Wound Repair Regen       Date:  2011-09       Impact factor: 3.617

7.  Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: effect of sodium dodecyl sulphate.

Authors:  P von den Driesch; M Fartasch; A Hüner; M Ponec
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Hyaluronan participates in the epidermal response to disruption of the permeability barrier in vivo.

Authors:  Edward V Maytin; Helen H Chung; V Mani Seetharaman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  Abnormalities in stratum corneum function in patients recovered from leprosy.

Authors:  S-P Song; C-Z Lv; K R Feingold; Q-N Hou; Z-Y Li; C-Y Guo; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2009-01-09       Impact factor: 3.479

10.  The use of a semiocclusive dressing reduces epidermal inflammatory cytokine expression and mitigates dermal proliferation and inflammation in a rat incisional model.

Authors:  Oliver Kloeters; Clark Schierle; Andrea Tandara; Thomas A Mustoe
Journal:  Wound Repair Regen       Date:  2008 Jul-Aug       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.